Setsuko K Chambers

h-index

Research activity per year

Fingerprint

Dive into the research topics where Setsuko K Chambers is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

133 Article
5 Chapter
5 Review article
2 Comment/debate
More

miR-449, identified through antiandrogen exposure, mitigates functional biomarkers associated with ovarian cancer risk
Wang, X., Woo, H. H., Wei, M., Gibson, S., Miranda, M., Rush, D., Cragun, J., Zheng, W., Yao, G. & Chambers, S. K., Dec 2024, In: Scientific reports. 14, 1, 29937.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Link opens in a new tab Scopus citations
Tolerability of the niraparib individualized starting dose in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy
Vulsteke, C., Chambers, S. K., Pérez, M. J. R., Chan, J. K., Raaschou-Jensen, N., Zhuo, Y., Lorusso, D., Herzog, T. J., de la Motte Rouge, T., Thomes Pepin, J. A., Braicu, E. I., Chen, L. M., Levy, T., Barter, J. F., Pilar Barretina-Ginesta, M., Joosens, E., York, W., Malinowska, I. A., González-Martín, A. & Monk, B. J., Sep 2024, In: European Journal of Cancer. 208, 114157.
Research output: Contribution to journal › Article › peer-review

Open Access
6 Link opens in a new tab Scopus citations
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer
Holloway, R. W., Thaker, P., Mendivil, A. A., Ahmad, S., Al-Niaimi, A. N., Barter, J., Beck, T., Chambers, S. K., Coleman, R. L., Crafton, S. M., Crane, E., Ramez, E., Ghamande, S., Graybill, W., Herzog, T., Indermaur, M. D., John, V. S., Landrum, L., Lim, P. C. & Lucci, J. A. & 12 others, Mchale, M., Monk, B. J., Moore, K. N., Morris, R., O'malley, D. M., Reid, T. J., Richardson, D., Rose, P. G., Scalici, J. M., Silasi, D. A., Tewari, K. & Wang, E. W., Sep 1 2023, In: International Journal of Gynecological Cancer. 33, 9, p. 1458-1463 6 p.
Research output: Contribution to journal › Article › peer-review

Open Access
18 Link opens in a new tab Scopus citations
A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006)
Tanyi, J. L., Randall, L. M., Chambers, S. K., Butler, K. A., Winer, I. S., Langstraat, C. L., Han, E. S., Vahrmeijer, A. L., Chon, H. S., Morgan, M. A., Powell, M. A., Tseng, J. H., Lopez, A. S. & Wenham, R. M., Jun 2023, In: Obstetrical and Gynecological Survey. 78, 6, p. 341-342 2 p.
Research output: Contribution to journal › Comment/debate › peer-review

1 Link opens in a new tab Scopus citations
A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006)
Tanyi, J. L., Randall, L. M., Chambers, S. K., Butler, K. A., Winer, I. S., Langstraat, C. L., Han, E. S., Vahrmeijer, A. L., Chon, H. S., Morgan, M. A., Powell, M. A., Tseng, J. H., Lopez, A. S. & Wenham, R. M., Jan 10 2023, In: Journal of Clinical Oncology. 41, 2, p. 276-284 9 p.
Research output: Contribution to journal › Article › peer-review

Open Access
126 Link opens in a new tab Scopus citations

4 Finished
5 Not started

Regulation of CSF-1 in Ovarian Cancer
Chambers, S. K. (CoPI)
Project: Research project
CSF-1 AND DRUG RESISTANCE IN REPRODUCTIVE CANCERS
Chambers, S. K. (PI)
Project: Research project
REGULATION OF C-FMS PROTO-ONCOGENE IN EPITHELIAL CANCERS
Chambers, S. K. (PI)
Project: Research project
REGULATION OF CSF 1 AND UROKINASE IN OVARIAN CANCER
Chambers, S. K. (PI) & Chambers, S. K. (CoPI)
Project: Research project
CONTEMPORARY APPROACHES TO OVARIAN CANCER
Chambers, S. K. (PI)
Project: Research project

Additional file 4 of Dissection of transcriptome dysregulation and immune characterization in women with germline BRCA1 mutation at single-cell resolution
Yu, X. (Creator), Lin, W. (Creator), Spirtos, A. (Creator), Wang, Y. (Creator), Chen, H. (Creator), Ye, J. (Creator), Parker, J. (Creator), Liu, C. C. (Creator), Wang, Y. (Creator), Quinn, G. (Creator), Zhou, F. (Creator), Chambers, S. K. (Creator), Lewis, C. (Creator), Lea, J. (Creator), Li, B. (Creator) & Zheng, W. (Creator), figshare, 2022
DOI: 10.6084/m9.figshare.21069666.v1, https://springernature.figshare.com/articles/dataset/Additional_file_4_of_Dissection_of_transcriptome_dysregulation_and_immune_characterization_in_women_with_germline_BRCA1_mutation_at_single-cell_resolution/21069666/1
Dataset
Additional file 3 of Dissection of transcriptome dysregulation and immune characterization in women with germline BRCA1 mutation at single-cell resolution
Yu, X. (Creator), Lin, W. (Creator), Spirtos, A. (Creator), Wang, Y. (Creator), Chen, H. (Creator), Ye, J. (Creator), Parker, J. (Creator), Liu, C. C. (Creator), Wang, Y. (Creator), Quinn, G. (Creator), Zhou, F. (Creator), Chambers, S. K. (Creator), Lewis, C. (Creator), Lea, J. (Creator), Li, B. (Creator) & Zheng, W. (Creator), figshare, 2022
DOI: 10.6084/m9.figshare.21069663.v1, https://springernature.figshare.com/articles/dataset/Additional_file_3_of_Dissection_of_transcriptome_dysregulation_and_immune_characterization_in_women_with_germline_BRCA1_mutation_at_single-cell_resolution/21069663/1
Dataset
Additional file 5 of Dissection of transcriptome dysregulation and immune characterization in women with germline BRCA1 mutation at single-cell resolution
Yu, X. (Creator), Lin, W. (Creator), Spirtos, A. (Creator), Wang, Y. (Creator), Chen, H. (Creator), Ye, J. (Creator), Parker, J. (Creator), Liu, C. C. (Creator), Wang, Y. (Creator), Quinn, G. (Creator), Zhou, F. (Creator), Chambers, S. K. (Creator), Lewis, C. (Creator), Lea, J. (Creator), Li, B. (Creator) & Zheng, W. (Creator), figshare, 2022
DOI: 10.6084/m9.figshare.21069669.v1, https://springernature.figshare.com/articles/dataset/Additional_file_5_of_Dissection_of_transcriptome_dysregulation_and_immune_characterization_in_women_with_germline_BRCA1_mutation_at_single-cell_resolution/21069669/1
Dataset
Additional file 3 of Dissection of transcriptome dysregulation and immune characterization in women with germline BRCA1 mutation at single-cell resolution
Yu, X. (Creator), Lin, W. (Creator), Spirtos, A. (Creator), Wang, Y. (Creator), Chen, H. (Creator), Ye, J. (Creator), Parker, J. (Creator), Liu, C. C. (Creator), Wang, Y. (Creator), Quinn, G. (Creator), Zhou, F. (Creator), Chambers, S. K. (Creator), Lewis, C. (Creator), Lea, J. (Creator), Li, B. (Creator) & Zheng, W. (Creator), figshare, 2022
DOI: 10.6084/m9.figshare.21069663, https://springernature.figshare.com/articles/dataset/Additional_file_3_of_Dissection_of_transcriptome_dysregulation_and_immune_characterization_in_women_with_germline_BRCA1_mutation_at_single-cell_resolution/21069663
Dataset
Additional file 4 of Dissection of transcriptome dysregulation and immune characterization in women with germline BRCA1 mutation at single-cell resolution
Yu, X. (Creator), Lin, W. (Creator), Spirtos, A. (Creator), Wang, Y. (Creator), Chen, H. (Creator), Ye, J. (Creator), Parker, J. (Creator), Liu, C. C. (Creator), Wang, Y. (Creator), Quinn, G. (Creator), Zhou, F. (Creator), Chambers, S. K. (Creator), Lewis, C. (Creator), Lea, J. (Creator), Li, B. (Creator) & Zheng, W. (Creator), figshare, 2022
DOI: 10.6084/m9.figshare.21069666, https://springernature.figshare.com/articles/dataset/Additional_file_4_of_Dissection_of_transcriptome_dysregulation_and_immune_characterization_in_women_with_germline_BRCA1_mutation_at_single-cell_resolution/21069666
Dataset

Setsuko K Chambers

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

miR-449, identified through antiandrogen exposure, mitigates functional biomarkers associated with ovarian cancer risk

Tolerability of the niraparib individualized starting dose in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy

A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer

A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006)

A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006)

Regulation of CSF-1 in Ovarian Cancer

CSF-1 AND DRUG RESISTANCE IN REPRODUCTIVE CANCERS

REGULATION OF C-FMS PROTO-ONCOGENE IN EPITHELIAL CANCERS

REGULATION OF CSF 1 AND UROKINASE IN OVARIAN CANCER

CONTEMPORARY APPROACHES TO OVARIAN CANCER

Additional file 4 of Dissection of transcriptome dysregulation and immune characterization in women with germline BRCA1 mutation at single-cell resolution

Additional file 3 of Dissection of transcriptome dysregulation and immune characterization in women with germline BRCA1 mutation at single-cell resolution

Additional file 5 of Dissection of transcriptome dysregulation and immune characterization in women with germline BRCA1 mutation at single-cell resolution

Additional file 3 of Dissection of transcriptome dysregulation and immune characterization in women with germline BRCA1 mutation at single-cell resolution

Additional file 4 of Dissection of transcriptome dysregulation and immune characterization in women with germline BRCA1 mutation at single-cell resolution

Setsuko K Chambers

Fingerprint

Collaborations and top research areas from the last five years

Scholarly Works

Grants

Datasets